NCT00362583View on ClinicalTrials.gov

Efficacy and Safety of Intranasal Fentanyl in the Treatment of Breakthrough Pain (FT-018-IM)

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

March 31, 2008

Conditions
Cancer
Interventions
DRUG

Fentanyl

Trial Locations (1)

4000

Nycomed, Roskilde

Sponsors

Lead Sponsor

Nycomed
All Listed Sponsors
lead

Nycomed

INDUSTRY